$17.39
2.11% today
Nasdaq, Aug 01, 10:00 pm CET
ISIN
US8257041090
Symbol
SIBN

SI-BONE, Inc. Stock price

$17.03
-1.79 9.51% 1M
+0.27 1.61% 6M
+3.01 21.47% YTD
+1.83 12.04% 1Y
+3.30 24.04% 3Y
-0.07 0.41% 5Y
-3.03 15.10% 10Y
-3.03 15.10% 20Y
Nasdaq, Closing price Thu, Jul 31 2025
-0.77 4.33%

Key metrics

Basic
Market capitalization
$725.7m
Enterprise Value
$616.8m
Net debt
positive
Cash
$144.4m
Shares outstanding
42.5m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
4.1 | 3.6
EV/Sales
3.5 | 3.1
EV/FCF
negative
P/B
4.3
Financial Health
Equity Ratio
72.5%
Return on Equity
-18.5%
ROCE
-15.1%
ROIC
-
Debt/Equity
0.2
Financials (TTM | estimate)
Revenue
$176.6m | $199.8m
EBITDA
$-26.1m | $-1.2m
EBIT
$-30.7m | $-31.0m
Net Income
$-26.6m | $-27.4m
Free Cash Flow
$-20.3m
Growth (TTM | estimate)
Revenue
22.6% | 19.5%
EBITDA
38.2% | 96.2%
EBIT
35.6% | 11.9%
Net Income
38.4% | 11.2%
Free Cash Flow
11.3%
Margin (TTM | estimate)
Gross
79.3%
EBITDA
-14.8% | -0.6%
EBIT
-17.4%
Net
-15.0% | -13.7%
Free Cash Flow
-11.5%
More
EPS
$-0.6
FCF per Share
$-0.5
Short interest
4.5%
Employees
349
Rev per Employee
$480.0k
Show more

Is SI-BONE, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,028 stocks worldwide.

SI-BONE, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a SI-BONE, Inc. forecast:

14x Buy
93%
1x Hold
7%

Analyst Opinions

15 Analysts have issued a SI-BONE, Inc. forecast:

Buy
93%
Hold
7%

Financial data from SI-BONE, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
177 177
23% 23%
100%
- Direct Costs 37 37
16% 16%
21%
140 140
24% 24%
79%
- Selling and Administrative Expenses 154 154
7% 7%
87%
- Research and Development Expense 17 17
4% 4%
9%
-26 -26
38% 38%
-15%
- Depreciation and Amortization 4.57 4.57
16% 16%
3%
EBIT (Operating Income) EBIT -31 -31
36% 36%
-17%
Net Profit -27 -27
38% 38%
-15%

In millions USD.

Don't miss a Thing! We will send you all news about SI-BONE, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

SI-BONE, Inc. Stock News

Neutral
GlobeNewsWire
3 days ago
SANTA CLARA, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming Canaccord Genuity 45th Annual Growth Conference in Boston, MA. Management will be hosting a fireside chat on Tuesday, August 12, 2025, at 12:00 p.m. Pacific Time/03:00 p.m....
Neutral
GlobeNewsWire
18 days ago
SANTA CLARA, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results for the second quarter of 2025 after market close on Monday, August 4, 2025. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Neutral
GlobeNewsWire
about 2 months ago
SANTA CLARA, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming 2025 Truist Securities MedTech Conference in Boston, MA.
More SI-BONE, Inc. News

Company Profile

SI-BONE, Inc. is a medical device company. It focuses on the development of implantable devices used in the surgical treatment of the sacropelvic anatomy. The firm's product, iFuse, seeks to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in San Jose, CA.

Head office United States
CEO Laura Francis
Employees 349
Founded 2008
Website si-bone.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today